PCF Pharma Compliance Congress XIX Video Content Now Available Online and via Flash Drive

Press Release: Pharma Compliance Congress XIX Video Content Now Available Online and via Flash Drive

Sponsored by the Pharmaceutical Compliance Forum

Held November 7 - 9, 2018

Onsite at the Mandarin Oriental, Washington, DC

Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months

Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update

www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com

THE 2018 NINETEENTH ANNUAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The Nineeenth Annual Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months).

YOU CAN PURCHASE JUST THE NINETEENTH ANNUAL PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of the 2018 Nineeenth Annual Pharma Congress Presentations!
$195
Order Now
Flash Drive of the 2018 Nineeenth Annual Pharma Congress Presentations!
$195
Order Now

SAMPLE PCF PHARMA CONGRESS VIDEO: ANNUAL CCO ROUNDTABLE

Click here to watch.

FEATURING

Jill Fallows-Macaluso, JD
Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ

Jonathon Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ

Robert A. Ladd, JD
Vice President, Global Head Integrity & Compliance, Oncology, Novartis; Former, General Counsel, GE Healthcare Partners; East Hanover, NJ

Puja Leekha, JD Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker Corporation, Deerfield, IL	Lori Queisser Sr VP and Global CCO, Teva, Former Sr. VP Global Compliance & Business Practices, Schering-Plough, Former VP & CCO, Eli Lilly, Former Co-chair, PCF, Horsham, PA
Eric Siegel, JD Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Former, Senior Investigator, City of Philadelphia Office of the Inspector General, Philadelphia, PA	Paul Silver Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- NOVEMBER 20, 2018: The Pharmaceutical Compliance Forum's Nineteenth Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, was held November 7 - 9, 2018 at the Mandarin Oriental in Washington, DC. The conference content is now available for purchase.

KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD	Leslie Backschies, MA Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA	Richard Bistrong, MA Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA
Hui Chen, JD Ethics and Compliance Advocate and Consultant, HC Ethics LLC; Former Compliance Counsel Expert (Consultant), US Department of Justice; Former Assistant General Counsel, Pfizer, New York, NY	Zachary A. Cunha, JD Assistant US Attorney and Chief, Civil Division, US Attorney's Office, District of Rhode Island, US Department of Justice, Former AUSA, District of Massachusetts and Eastern District of New York, Providence, RI	Susan Dentzer President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
Jacob Elberg, JD Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ	Christopher B. Harwood, JD Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney's Office, Southern District of New York, Former Assistant US. Attorney, US Attorney's Office for the District of Columbia, US Department of Justice, New York, NY	Tarek Helou, Esq. Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Rachael Honig, JD First Assistant US Attorney, US Attorney's Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY	Mary E. Riordan, Esq. Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
Gregg Shapiro, JD Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA	Sally Q. Yates, JD Partner, King and Spalding; Former Acting Attorney General; Former Deputy Attorney General; Former US Attorney; Former Assistant US Attorney, US Attorney's Officer, Northern District of Georgia, US Department of Justice, Washington, DC

AGENDA-AT-A-GLANCE

WEDNESDAY, NOVEMBER 7

FEATURING AN INVITATION-ONLY CCO ROUNDTABLE

Hosted by PCF and PhRMA CCO Working Group; Featuring Hui Chen, JD, HC Ethics LLC

PRECONFERENCE SESSIONS

Patient Support Programs: Risk and Risk Management Best Practices
Practical Approaches to Handling Investigations
Advanced Strategies in Auditing and Monitoring
Asking the Right Risk Questions to Power your Advanced Analytics Strategy

PLENARY SESSIONS

OIG Keynote Address
FDA Keynote Address
Risks Your Risk Assessment Might Miss
Chief Compliance Officer Roundtable

THURSDAY, NOVEMBER 8

PLENARY SESSIONS

Sally Yates Keynote Address
Annual AUSA Roundtable
Annual Qui Tam Roundtable
DOJ, FBI and SEC FCPA Enforcement Update
Patient Support Programs Roundtable
Pharma and Device Pricing and Cost Containment

MINI SUMMITS

Fostering a Culture of Ethics and Compliance
Global Compliance Function Harmonization
Third Party Lifecycle Management
Annual Medical Device Compliance Roundtable

MINI SUMMITS, CONTINUED...

Dissecting Recent CIAs and Review of Draft Model CIA
Strategies to Measure Effectiveness, Monitor and Report
Managing Promotional Programs and Patient Advocacy Groups
Open Payments: Where Does the Sun Shine Now?
Interactions with Specialty Pharmacy
Is your Board Bored of your Compliance Dashboards?
Next Generation Data Analytics Promotion with Medical Professionals: Avoiding White Coat Marketing
Market Access Compliance Considerations
Global Documentation Framework
R&D: Hidden Risks beyond Clinical Trail Recruitment
Compliance for Small to Mid-size Pharma and Device Companies
Compliance Issues Associated with PBM Relationships
Risk Assessments and Mitigation Plans
"All in Compliance" -- Aligning with Your Business Partners
Navigating the Murky Waters of Patient Programs
Compliance for "Evolved" Products, including Aesthetics and Gene Therapy
Best Practice in HCP/HCO Management
Compliance Considerations in Value-based Contracting
Risks and Opportunities related to Medical Affairs
An Interactive Case Study in Effective Crisis Management
Privacy and Cybersecurity Compliance Update, including GDPR
The Compliance Training Revolution

FRIDAY, NOVEMBER 9

INDUSTRY-ONLY BEST PRACTICES ROUNDTABLE

Featuring AUSA Gregg Shapiro, JD

FEATURED FACULTY

James Accumanno, JD Director Risk, Monitoring and Auditing, Novo Nordisk, Former Associate Counsel, Bayer, Philadelphia, PA	Anthony Alvizu, CPA, EnCE, CFE Managing Director, Global Risk & Investigations Practice (GRIP), FTI Consulting, Chicago, IL	Eliza L. Andonova, JD Counsel, Hogan Lovells, Washington, DC	Timothy Ayers, JD, MPH Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL
Eric Baim, JD Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA	Yogesh Bahl, CPA, MBA Managing Director, Alix Partners, New York, NY	Minna Bak, MBA Senior Manager, Helio Health Group, New York, NY	Jennifer Barbre, MBS Executive Director, Compliance, Spectrum Pharmaceuticals, Inc., Former Director, Compliance and Ethics Program, Avanir, Irvine, CA
Dennis K. Barnes, JD, MBA, CPA Vice President, Global Governance, Risk and Compliance, Mayne Pharma, Raleigh-Durham, NC	Scott Bass, JD Partner and Head, Global Life Sciences Team, Sidley Austin LLP, New York, NY	Ann E. Beasley, JD Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA	Thomas Beimers, JD Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Minneapolis, MN and Washington, DC
Chuck Bell, JD, BSN President, Arete Resources, Inc.; Former Compliance Officer, Kedrion Biopharma Inc.; Former Interim Compliance Officer, Insmed Inc.; New York, NY	John T. Bentivoglio, Esq. Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC	Andrew Blasi Director, C&M International, Crowell & Moring, Former Pamela Harriman Foreign Service Fellow, US Embassy in London, Former Congressional Liaison, Australian Embassy and Foreign Affairs Subcommittee on Europe, US House of Representatives, Washington, DC	Brian A. Bohnenkamp, MHA, JD Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC
Christine N. Bradshaw, JD Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ	Julianne Brierley Director, Head of Compliance Learning, Novartis, New York, NY	Katherine Buckley, MBA Partner, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA	Terra Buckley, JD Executive Director, US HCC Business Advisory Center of Excellence, Celgene, Former Head, US Compliance, Helsinn, Summit, NJ
Ed Buthusiem, JD Managing Director, Berkeley Research Group, Adjunct Professor Of Law, Temple University, Former SVP, R&D Legal Operations & Vaccines, GSK, Devon, PA	Joseph Calarco Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA	Christie Camelio Vice President and US Healthcare Compliance Officer, Celgene, Former Head of Risk Management, Novartis, Summit, NJ	Regina G. Cavaliere, JD Principal, Regulatory Enforcement & Compliance, Life Sciences Sector, KPMG LLP, Former VP and CCO, Otsuka America, Short Hills, NJ
Nicole Chandonnet, JD Associate, Covington & Burling, Washington, DC	Katherine Chaurette, JD Senior Director, Assistant General Counsel, Regeneron Pharmaceuticals, Inc., Boston, MA	Jennifer Chillas, JD Senior Corporate Counsel, Bristol-Myers Squibb; Former Associate, Ropes & Gray, LLP; Princeton, NJ	Craig Chiulli, MBA Group Product Director, Metabolic Franchise, Johnson & Johnson, Titusville, NJ
Craig Clesson, JD, CIPP/US Assistant General Counsel and Global Privacy Officer, Syneos Health; Former Vice President and Ethics and Compliance Officer, Aegerion; Boston, MA	William Connelly, JD Senior Counsel, Amgen; Former Staff Attorney, US DHHS, Washington, DC	Kellie Branson Combs, JD Partner, Ropes & Gray LLP, Washington, DC	Lynn Costa Senior Policy Advisor for the Western Hemisphere, U.S. Department of Commerce, Washington, DC
Thomas Costa, JD Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC	Clarissa Crain Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA	Jill Dailey, MBA, JD Vice President & Chief Compliance Officer, Incyte, Former AG, Asia Pac Lead, Pfizer, Former Head, US Ethics and Compliance, Novartis, New York, NY	Meenakshi Datta, JD Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
Mahnu V. Davar, JD Partner, Arnold & Porter Kaye Scholer LLP, Lecturer, University of Pennsylvania Law School, Fellow, Salzburg Global Seminar, Washington, DC	BJ D'Avella, MBA Senior Manager, Life Sciences Advisory, Deloitte & Touche LLP, Parsippany, NJ	Sharon R. Delshad, JD Director, Compliance and Legal Affairs, Nalpropion, Former Director, Compliance and Legal Affairs, Orexigen Therapeutics, San Diego, CA	Gary Del Vecchio Health Care CO Cardiovascular & Metabolism, Janssen, Former ED US Pharma Compliance & Ethics, Bristol-Myers Squibb, Former PCF Co-chair, New York, NY
Mark A. DeWyngaert, MBA, PhD Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY	Sarah diFrancesca, JD Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY	Christian A. Dingler Managing Consultant, Navigant Consulting, Richmond, VA	Stefanie A. Doebler, JD Of Counsel, Covington & Burling LLP, Washington, DC
Suzanne E. Durrell, JD Managing Member, Whistleblower Law Collaborative, LLC, Taxpayers Against Fraud Education Fund, 2017 Whistleblower Lawyer of the Year, Boston, MA	Michael Dusseau Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, Madison, NJ	Eileen Erdos Principal, Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL	Melanie Fagan HCP Engagement Lead, Medical Affairs Compliance, GlaxoSmithKline, Philadelphia, PA
J. Mark Farrar, CPA, CFE, CFF Managing Director, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA	Alison Fethke, JD Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL	Kellie Fidler, MBA, PMP Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton Pike, NJ	Paul Fishman, JD Partner and Head, Crisis Management and Strategic Response Team, Arnold & Porter LLP, Former United States Attorney, District of New Jersey, Washington, DC
Sarah A. Franklin, JD Partner, Covington & Burling LLP, Former Attorney, Federal Trade Commission, Washington, DC	Charlene Keller Fullmer, JD Assistant United States Attorney and Deputy Chief, Affirmative Litigation, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA	Andrew Furlow, JD Senior Associate, Hogan Lovells US LLP, New York, NY	Alex Ganz, JD Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA
Nereyda Garcia, JD Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA	Gary F. Giampetruzzi, Esq. Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY	Virginia "Ginny" A. Gibson, JD Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA	Jonathan Glazier, JD, MBA Head, Legal Compliance, Philips, Former Sr. Dir., Corporate Compliance and Privacy Officer, Fresenius, Andover, MA
Wendy C. Goldstein, JD Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY	Anthony Greco, MBA Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA	Adam Greene, JD, MPH Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior HIT & Privacy Specialist, OCR, DHHS, Washington, DC	Lillian S. Hardy, JD Partner, Hogan Lovells LLP, Washington, DC
Patricia J. Harned, PhD Chief Executive Officer, ECI (Ethics and Compliance Initiative), Former President, Ethics Resource Center, Washington, DC	Kate Heinzelman, JD Counsel, Sidley Austin LLP, Former Deputy GC, US DHHS, Former Special Assistant and Associate Counsel, President Barack Obama, Washington, DC	Laura G. Hoey, JD Co-leader, Government Enforcement and White Collar Group and Health Care and Life Sciences Industry Group, Ropes & Gray LLP, Chicago, IL	Casey J. Horton, CFE Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL
Emily Huebener, MA Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL	Erinn Hutchinson Partner, Advisory Services, PwC, Philadelphia, PA	Elizabeth Jobes, JD Head, Corporate Compliance & Legal Counsel, Spark, Former Senior VP & CCO, Auxilium, Former PCF Co-chair, Philadelphia, PA	Darren R. Jones Partner, Global Compliance Consulting Leader, Polaris Management, New York, NY
Marci Juneau, MBA Partner, Helio Health Group, Atlanta, GA	Kiley Smith Kelly, MBA Partner, Forensic and Integrity Services, Ernst & Young LLP, Philadelphia, PA	Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC	Daniel A. Kracov, JD Partner, Arnold & Porter Kaye Scholer LLP, Washington, DC
Daryl Kreml, JD VP & CCO, Sage, Former Head, US Compliance & Global Program Management, Biogen, Former Dir. & Sen. Managing Counsel, Int'l Compliance, Boston Scientific, Boston, MA	Joseph Lake, MS Global Healthcare Compliance & Third Party Monitoring Lead, Bristol-Myers Squibb, Former Group Internal Audit, Sanofi, Former Director, Global Compliance Organization, Merck, Morristown, NJ	Marc Levine Director of Compliance, Insightec, Former Compliance Officer, Stryker Corporation, Former Business Conduct Specialist, MAKO Surgical, Fort Lauderdale, FL	Jonathan Levy, JD Corporate Compliance Counsel, Spark Therapeutics; Former Associate Director of Compliance and Ethics, US Pharmaceuticals, Bristol-Myers Squibb; Philadelphia, PA
Jodi Lindsey, JD Senior Director & Head of US Healthcare Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, Boston, MA	Richard Liner, JD Senior Counsel, Compliance and Investigations, Bayer, Whippany, NJ	Chad Londeree Healthcare Industry Group Leader, SAI Global, Richmond, VA	Pamela Lonzer, MSJ Ass. Dir., Medical Operations, Compliance & Controls, Alexion, Former Ass. Dir. & US Medical Advisor, Global Compliance & Risk Management, Shire, Chicago, IL
Seth H. Lundy, JD Partner, King & Spalding, Washington, DC	Ali Lyons Director, Ethics and Compliance, Aegerion Pharmaceuticals; Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA	Joe Mack, JD Senior Compliance Counsel, Bayer, Former Assistant United States Attorney and Deputy Chief, Health Care and Government Fraud Unit, US Attorney's Office, District of New Jersey, New York, NY	Stephanie Macholtz, JD, MBA Director, Compliance and Ethics, Global Medical Affairs and Business Development, Alexion Pharmaceuticals, Inc.; Former Compliance Officer, Biogen, Boston, MA
Colette G. Matzzie, JD Partner, Phillips & Cohen LLP, Former Civil Appellate Staff and Trial Attorney, Tobacco Litigation Team, US Department of Justice, Washington, DC	Tara McCarthy, JD Partner, Dovetail Consulting Group, Former Senior Vice President, GC and Secretary at Chiasma, Former Vice President of Commercial Law at Vertex, Boston, MA	Dennis McCloskey, JD Compliance Officer, Olympus Corporation of the Americas, Former Assistant District Attorney, Homicide Unit, Philadelphia District Attorney's Office, Philadelphia, PA	Vickie L. McCormick Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ
Jennifer McGee, JD Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD	Jean McKiernan, MBA Director, Pharmaceutical and Life Sciences Advisory Practice, PwC, Chicago, IL	Jason P. Mehta, JD Partner, Bradley Arant Boult Cummings LLP, Former Assistant United States Attorney, US Attorney's Office for the Middle District of Florida, US Department of Justice, Tampa, FL	Stephanie J. Meltzer, JD Vice President and Assistant General Counsel, Innovative Health, Pfizer, Former Assistant United States Attorney, United States Attorney's Office, District of Columbia, US Department of Justice, New York, NY
Kathleen Meriwether, JD Americas Leader - Life Science, Forensic & Integrity Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA	Vahan Minassian, JD Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA	Gregory S. Moss, JD Senior Vice President, Deputy General Counsel, Kadmon Corporation, New York, NY	Melissa Murphy, MBA Senior Compliance Specialist, Office of Ethics & Compliance, Medtronic, Minneapolis, MN
Aneta Nastaj, MS Training Manager, Corporate Research and Investigations, South Quay, London, UK	Kamleh J. Nicola, LLB Partner, Baker & McKenzie LLP, Toronto, Canada	Chrisoula Nikidis Canadian Head of Compliance and Ethics Solutions, IQVIA; Former Executive Director, Ethics and Compliance, Innovative Medicines Canada, Ottawa, Canada	Katherine Cartwright Norris, MPA Dir., Berkeley Research Group, Former Sr Dir., Compliance, NSF Health Sciences, Former Dir., Corporate Compliance, Spectranetics, Washington, DC
Susan P. Novak Director, Corporate Policies Global Compliance, Celgene Corporation; Former Director of Compliance, Sandoz; Summit, NJ	Adam Oakley Director, Potomac River Partners, Arlington, VA	Josh T. O'Harra, MS, JD Assistant General Counsel, Eli Lilly and Company; Former Sr. Associate, King & Spalding, Washington, DC	Agatha O'Malley, MStPH, JD Privacy Officer and Senior Counsel, Otsuka Pharmaceuticals (US), Former Director - Head of Privacy, Shire, Philadelphia, PA
David W. Opderbeck, JD Professor of Law, Seton Hall University Law School; Counsel, Gibbons PC, Newark, NJ	Tricia Van Orden Deputy Director, Trade Promotion Coordinating Committee Secretariat, International Trade Administration, US Department of Commerce, Washington, DC	John Patrick Oroho, JD Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ	Amy Pawloski Compliance Officer - Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA
Roy Pollitt Managing Director, Americas Head, Investigations, Exiger, Former Special Agent, Federal Bureau of Investigation, New York, NY	Perri Pomper, JD Director of Compliance, Clinical Genomics; Former Director, Ethics and Compliance Strategy & Education, Novo Nordisk, New York, NY	John Seungjoo Rah, JD Partner at DLA Piper, Washington, DC	Kelly N. "Nikki" Reeves, MPA, JD Partner, King & Spalding LLP, Washington, DC
Francisco Ribeiro Senior Director & Head of US Compliance, Tesaro, Inc., Former Sr. Dir., Corporate Compliance, Biogen, Former Sr. Dir., International Markets, Sandoz, Boston, MA	John C. Richter Partner, King & Spalding, Washington, DC	Margaret Erin Rodgers-Schmidt, JD Partner, Morgan Lewis & Bockius, Philadelphia, PA	Jeffrey Rosenbaum, MBA Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
David Ryan, JD Vice President and Chief Compliance Officer, Epizyme, Former Vice President, Associate GC and CCO, Haemonetics, Boston, MA	Mark Scallon, MHA Senior Principal, Polaris, IQVIA Global Compliance, Richmond, VA	Cheryl J. Scarboro, JD Partner, Simpson Thacher & Bartlett, Former, Chief, FCPA Unit, Enforcement Division, US SEC, Washington, DC	Angela Schwartz, JD Senior Manager, Fraud Investigations & Dispute Services, Life Sciences, EY, Philadelphia, PA
Sue Seferian, JD Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ	George Serafin, MS National Health Care and Life Sciences Leader, Grant Thornton, LLP, Iselin, NJ	Nicole Serena Director, PSP Consulting Services, MATRIX Healthcare Strategists Inc.; Former Director, Patient Access, Bayer; Canada	Patterson Shafer Managing Director, Health Care and Life Sciences, Grant Thornton, Stamford, CT
Michael Shaw, JD Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Senior Counsel, Office of Inspector General, US DHHS, Former PCF Co-chair, Philadelphia, PA	Eric Siegel, JD Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Former, Senior Investigator, City of Philadelphia Office of the Inspector General, Philadelphia, PA	Laura (Munns) Skinner, MBA Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX	Jon Smollen, MA, JD Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA
Eugene F. Soltes, MBA, PhD Jakurski Family Associate Professor of Business Administration, Harvard Business School, Author, Why They Do It: Inside the Mind of the White-Collar Criminal, Cambridge, MA	Tim Stow, JD Senior Vice President and Head of Legal International, Shire, Former VP, Head of Legal Europe, International & Asia Pacific, UCB, Boston, MA	Silvija A. Strikis, JD Partner, Kellogg Hansen Todd, Figel & Frederick, Former Law Clerk, Justice Sandra Day O'Connor, US Supreme Court, Washington, DC	Ravi Tayi, MD, MPH Chief Medical Officer, US Ferring Pharmaceuticals; Former Vice President, Global Medical Affairs, Mallinckrodt; Former Vice President, Medical Affairs and Clinical Development, Cubist/Optimer, New York, NY
Ann-Marie Tejcek, MA Senior Director, Ethics & Compliance, Eli Lilly and Company, Indianapolis, IN	Bryan Timer, MA Business Analytics Director, Data Analytics & Transparency, Merck, North Wales, PA	Nancy Schwalje Travis, MIA Vice President, International Compliance and Governance, AdvaMed, Former Deputy Director, Office of Economic Policy, Asia-Pacific Bureau, US Department of State, Washington, DC	Brian Van Hoy Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ
Jennifer Vondee, MPH Manager, Pharmaceutical & Life Sciences Risk Consulting, PwC, Durham, NC	Julie Ritchie Wagner, JD Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC	Lisa Walkush, EMTM Partner, Grant Thornton, LLP, Philadelphia, PA	William Weinreb, JD Partner, Quinn Emanuel, Former Acting United States Attorney and First Assistant US Attorney, Boston, Boston, MA
Sarah Whipple, JD Senior Corporate and Compliance Counsel, Akebia Therapeutics, Inc., Former VP, Global Compliance & Privacy Officer, Aegerion, Former CCO and Assoc. GC, AMAG, Boston, MA	Donna White Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC	Seth B. Whitelaw, JD, LLM, SJD President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, West Chester, PA	Jonathan Wilkenfeld, MBA Partner, Potomac River Partners, Washington, DC

Russell Williams
Vice President, Government Relations and Public Affairs, Diabetes Canada, Patient Co-Chair, APEC Biopharmaceutical Working Group, Former President, Innovative Medicines Canada - M�dicaments novateurs Canada, Ottawa, Canada

Kathryn "Katie" E. Winson
Senior Manager, US HCC Monitoring, Celgene Corporation, Summit, NJ

Christina Woods
Manager, Pharmaceutical and Life Sciences Advisory, PwC, New York, NY

2018-2019 GLOBAL PHARMA COMPLIANCE CONGRESSES

NINETEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 -- 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com

THIRTEENTH INTERNATIONAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
April 8 -- 10, 2019
Grand Hyatt Athens
Athens, Greece
www.International PharmaCongress.com

NINTH ASIA PACIFIC PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September, 2019
Shanghai, China
www.Asian PharmaCongress.com

SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

CONGRESS CO CHAIRS

Michael R. Clarke, JD
Vice President, Corporate Compliance, Indivior Inc., Richmond, VA
(PCF Co-Chair)

Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ
(PCF Secretary)

Jeffrey M. Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., Basking Ridge, NJ
(PCF Chair)

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
(PCF Treasurer)

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ
(PCF Co-Chair)

Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ
(PCF Co-Chair)

GRANTORS:

GOLD

SILVER

BRONZE

CONTINUING EDUCATION CREDITS

Accounting Professionals: Approved for up to 19.0 NASBA CPE Credits for onsite attendance only.

Attorneys: Approval for up to 1.00 Ethics and 13.50 Pennsylvania MCLE credits.

Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)� and is currently pending their review for continuing education.

Click here for more information.

MEDIA PARTNERS:

PLANNING COMMITTEE

CO-CHAIRS

Michael R. Clarke, JD
Vice President, Corporate Compliance, Indivior Inc. (PCF Co-Chair)

Sujata T. Dayal, JD
Vice President, Health Care Compliance and Privacy, Pharmaceuticals Group, Johnson & Johnson (PCF Secretary)

Jeffrey M. Kawalek, MBA
Senior Director, Ethics and Compliance, North America, Ipsen Biopharmaceuticals, Inc. (PCF Chair)

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc. (PCF Treasurer)

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US (PCF Co-Chair)

Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals (PCF Co-Chair)

MEMBERS

Kamil Ali-Jackson, JD
Co-Founder, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary, Aclaris Therapeutics, Inc.

Michael Arbini
Global Marketing Communications Leader, Polaris Management

Timothy Ayers, JD, MPH
Group Vice President, Chief Compliance Officer, Horizon Pharma PLC

Dennis K. Barnes, JD, CPA
Vice President, Global Governance, Risk and Compliance, Mayne Pharma

Scott Bass, JD
Partner and Head, Global Life Sciences Team, Sidley Austin LLP

Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant

John T. Bentivoglio, JD
Partner, Skadden Arps LLP

Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law

Scott Boyance
Associate Director, Forensic and Integrity Services, EY

Joseph Calarco
Chief Compliance Officer, Neos Therapeutics

Christie Camelio
Vice President and US Healthcare Compliance Officer, Celgene Corporation

Thomas Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance and Ethics, Bristol-Myers Squibb

Paul Curtin, JD, CFE
Vice President, Global Chief Compliance Officer, Intercept Pharmaceuticals

Jill Fallows-Macaluso, BSN, JD
Vice President and Chief Compliance Officer, Novo Nordisk Inc.

Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP

Alison Fethke, JD
Counsel, Ropes & Gray LLP

Alex Ganz, JD
Senior Manager of Compliance, Aegerion Pharmaceuticals

Gary F. Giampetruzzi, JD
Partner, Paul Hastings

Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells

Jonathan Glazier, JD, MBA
Head of Legal Compliance, Philips North America LLC

Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP

Ive Grgas, MS
Director, Healthcare Compliance, Puma Biotechnology

Karen L. Hale, JD
Vice President, Chief Ethics & Compliance Officer, Abbvie

Bill Hrubes, MS
Vice President and Chief Compliance Officer, ACell, Inc.

Erinn Hutchinson
Partner, Advisory Services, PwC

Michael Joachim, JD
Compliance Business Partner, Sanofi Genzyme

Jonathon L. Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC

Daniel A. Kracov, JD
Partner and Head, FDA and Healthcare Practice, Arnold & Porter Kaye Scholer, LLP

Holly Kramen, JD
Chief Compliance Officer and Privacy Officer, PolarityTE

Robert A. Ladd, JD
Vice President, Global Head Integrity & Compliance, Oncology, Novartis

Puja Leekha, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance Lundbeck

Gregory Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation

Katherine Norris
Director, Berkeley Research Group

Neil F. O'Flaherty, JD
Partner, Baker Mckenzie

John Patrick Oroho, JD
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC

Jennifer O'Toole
Events Manager, Americas, SAI Global

Amy Pawloski
Compliance Officer, Operations, Endo Pharmaceuticals

Lori Queisser
Senior Vice President and Global Chief Compliance Officer, Teva

David Ralston, JD, MPH
Senior Director, Associate General Counsel, Business Conduct, Gilead Sciences

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding

Jeffrey Rosenbaum, MBA
Partner, Dovetail Consulting Group, LLC

Michael Shaw, JD
Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline

Paul J. Silver
Principal, Deloitte

Ann-Marie Tejcek, MA
Senior Director, Ethics and Compliance, Eli Lilly and Company

Brian Van Hoy
Vice President, G&M Health LLC

Donna Wachman
National Industry Marketing Leader, Grant Thornton LLP

Julie Wagner, JD
Assistant General Counsel, PhRMA

Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation

Donna White
Vice President, Contracts and Compliance, Chiesi USA, Inc.

Seth B. Whitelaw, JD, LLM, SJD
President and CEO, Whitelaw Compliance Group, LLC

STAY CONNECTED

Tweet using #PharmaCongress

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels

2008 - Paris

2009 - Rome

2010 - Berlin

2011 - Istanbul

2011 - Singapore

2012 - Budapest

2012 - Shanghai

2012 - São Paulo

2013 - Madrid

2013 - Kuala Lumpur

2014 - Dubai

2014 - Mexico City

2014 - Shanghai

2015 - Manila

2016 - Warsaw

2017 - Lisbon

2018 - Vienna